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Original ArticlePatients Allergic to Fish Tolerate Ray Based on the
Low Allergenicity of Its ParvalbuminTanja Kalic, MSca, Francoise Morel-Codreanu, MDb, Christian Radauer, PhDa, Thimo Ruethers, MScc, Aya C. Taki, PhDc,
Ines Swoboda, PhDd, Christiane Hilger, PhDe, Karin Hoffmann-Sommergruber, PhDa, Markus Ollert, MD, DMSce,f,
Christine Hafner, MDg,h, Andreas L. Lopata, PhDc, Martine Morisset, MD, PhDb, Heimo Breiteneder, PhDa, and
Annette Kuehn, PhDe Vienna and St Poelten, Austria; Esch-sur-Alzette, Luxembourg; Townsville, Queensland, Australia; and
Odense C, DenmarkWhat is already known about this topic? Patients allergic to fish are generally advised to avoid all types of fish. Most of
these patients are sensitized to bony fish and their major allergen parvalbumin. The allergenicity of cartilaginous fish, a
potential dietary alternative, is not well understood.
What does this article add to our knowledge? We demonstrated tolerance of ray, a cartilaginous fish, by patients with
allergy to bony fish. Furthermore, ray parvalbumin showed lower allergenicity than did the parvalbumins from bony fish.
How does this study impact current management guidelines? Current diagnosis of fish allergy focuses on bony fish.
Inclusion of cartilaginous fish and their parvalbumins in routine diagnosis of fish allergy may prevent unnecessary food
restrictions.BACKGROUND: Clinical reactions to bony fish species are
common in patients with allergy to fish and are caused by
parvalbumins of the b-lineage. Cartilaginous fish such as rays
and sharks contain mainly a-parvalbumins and their
allergenicity is not well understood.
OBJECTIVE: To investigate the allergenicity of cartilaginous
fish and their a-parvalbumins in individuals allergic to bony
fish.
METHODS: Sensitization to cod, salmon, and ray among
patients allergic to cod, salmon, or both (n [ 18) was explored
by prick-to-prick testing. Clinical reactivity to ray was assessed
in 11 patients by food challenges or clinical workup. IgE-
binding to b-parvalbumins (cod, carp, salmon, barramundi,
tilapia) and a-parvalbumins (ray, shark) was determined by
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RESULTS: Tolerance of ray was observed in 10 of 11 patients.
Prick-to-prick test reactions to ray were markedly lower than to
bony fish (median wheal diameter 2 mm with ray vs 11 mm with
cod and salmon). IgE to a-parvalbumins was lower (median, 0.1
kU/L for ray and shark) than to b-parvalbumins (median, ‡1.65
kU/L). Furthermore, a-parvalbumins demonstrated a signifi-
cantly reduced basophil activation capacity compared with b-
parvalbumins (eg, ray vs cod, P < .001; n[ 18). Skin prick test
further demonstrated lower reactivity to a-parvalbumins
compared with b-parvalbumins.
CONCLUSIONS: Most patients allergic to bony fish tolerated
ray, a cartilaginous fish, because of low allergenicity of its
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patients’ diet.  2018 The Authors. Published by Elsevier
Inc. on behalf of the American Academy of Allergy, Asthma
& Immunology. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/). (J Allergy Clin Immunol Pract 2019;7:500-8)
Key words: Parvalbumin; Fish allergy; Cod; Ray; Food chal-
lenge; Basophil activation; Skin prick test; IgE
INTRODUCTION
Fish allergy is typically a life-long disease with symptoms of
varying severity including life-threatening anaphylaxis.1,2 During
the evolution of jawed vertebrates, 2 classes of fish developed,
cartilaginous (Chondrichthyes) and bony fish (Osteichthyes).3
Although most of the studies focusing on fish allergy have
described bony fish as the primary allergen source, the allerge-
nicity and cross-reactivity of cartilaginous fish is not well un-
derstood.4-7
The prevalence of fish allergy ranges from 0.2% to 3% in the
general population and up to 8% in occupational settings.8-10
Increasing rates of allergic sensitization to fish may be linked
to the increasing worldwide production and consumption of
fish.11 As of 2015, annual per capita fish consumption in the
European Union was about 25 kg, while in the Asia-Pacific
region over 100 kg was reached.12,13
The most frequently consumed fish species belong to the bony
fish. In the European Union, the top 5 consumed species in
2014 were tuna, cod, salmon, Alaska pollock, and herring.13 In
the United States, the most commonly consumed species include
anchovy, Alaska pollock, and herring.13 In Asia, the variety of
eaten species is enormous and often include tilapia, carp, and
barramundi.12 Cartilaginous fish, including rays and sharks, are
also commonly traded and consumed worldwide.10,14 In Europe,
shark meat is commonly consumed in Spain and Italy.15
The diversity of consumed fish species and the increase in
their global availability pose a challenge for accurate diagnosis
and management of patients with fish allergy. Diagnostic tests for
fish allergy use a limited number of only bony fish species. They
do not include cartilaginous fish.16 The potential risk of reacting
to multiple fish species, along with the lack of comprehensive
and accurate diagnostic products, often results in the recom-
mendation of complete avoidance of all fish to patients
presenting to the clinic with fish allergy.17,18 This may adversely
affect the nutritional requirements and the quality of life of
affected individuals.19
The major fish allergen parvalbumin is a heat-stable,
intracellular EF-hand calcium-binding protein of low molecular
weight (10-14 kDa).20,21 It is abundant in fast-twitch white
muscle where it is involved in muscle relaxation.22 In addition,minor allergens such as aldolase A and b-enolase have been
identified and were demonstrated to be heat-sensitive.23 Parval-
bumins are present in all vertebrates and are divided into 2
evolutionary sublineages, a and b, which have different
biochemical properties.21 Although b-parvalbumins are abun-
dant in bony fish, a-parvalbumins are mainly found in carti-
laginous fish and higher vertebrates.4 Bony fish b-parvalbumins
are predominant sensitizers and often cross-reactive.4,24
Regarding the allergenicity of fish a-parvalbumins, there is
only 1 report demonstrating binding of patients’ IgE to
a-parvalbumin from red stingray.25
An in-depth investigation of the allergenicity of cartilaginous
fish and their parvalbumins has not been performed yet. We
conducted a comprehensive study characterizing the clinical
reactivity of patients with bony fish allergy to ray, a cartilagi-
nous fish. Furthermore, we analyzed patients’ IgE reactivity to
parvalbumins from both bony and cartilaginous fish using
ELISA, basophil activation test (BAT), and skin prick test
(SPT).METHODS
Study subjects
Eighteen individuals with fish allergy were recruited from the
Centre Hospitalier de Luxembourg (Table I). Criteria for study
participation included a documented clinical history of fish allergy
and positive ImmunoCAP (Thermo Fisher Scientific, Waltham,
Mass) for cod, salmon, or both. Total IgE was measured using
ImmunoCAP. The study was approved by the National Committee
for Medical Research Ethics in Luxembourg (Ref. 201307/04).
Seven individuals with allergies other than to fish were used as
controls in ELISA and BAT (Table E1 in this article’s Online Re-
pository at www.jaci-inpractice.org). Informed written consent was
obtained from all participants or their legal representatives.Prick-to-prick testing and clinical reactivity to bony
and cartilaginous fish
All patients allergic to fish were subjected to prick-to-prick tests
(PPTs) with boiled (20 minutes) bony (Atlantic cod, salmon, or
both) and cartilaginous fish (thornback ray) meat. Glycerin-
containing saline and 0.1% histamine dihydrochloride were used
as negative and positive controls, respectively. An average wheal
diameter of greater than or equal to 3 mm compared with negative
control was rated positive.
Information about clinical reactivity to cod and salmon, based on
history of allergic symptoms after eating specific fish, was obtained
from all patients. Clinical reactivity to ray by oral exposure was
assessed according to the procedure described in Figure E1 in this
article’s Online Repository at www.jaci-inpractice.org. Briefly, PPT
with ray was performed in all 18 patients. Eleven patients
(10 negative and 1 positive in PPT with ray) agreed to be tested for
potential tolerance of ray either by food challenge or by following
recommendations to introduce eating ray at home. Of these, 8
patients consumed a serving dose of ray (200 g for adults, 100 g for
children) at least twice. In addition, 2 patients (P4 and P14) were
subjected to open food challenges because they were apprehensive to
directly introducing ray in the diet. One patient (P18), with a
positive PPT result to ray, was subjected to a double-blind placebo-
controlled food challenge performed according to previously
published procedures.26
TABLE I. Demographic and clinical characteristics of patients allergic to fish
Patient Age (y)/sex
Fish allergy
symptoms Total IgE (kU/L)
ImmunoCAP (kUA/L) PPT (mm) Clinical reactivity
Cod Salmon Cod Salmon Ray Cod Salmon Ray
1 19/F A, AE, U 294 1.5 3.1 15 10 2 þ þ ND
2 7/M U, OAS 2244 0.2 7.9 0 10 0  þ 
3 12/F AE, U, OAS, V 352 5.9 5.4 8 10 2 þ þ 
4 8/M A, U 828 9.8 5.0 10 12 3 þ þ *
5 13/M AE, AP, U, V 2005 1.6 0.9 22 21 0 þ þ ND
6 35/M A, U 46 12.0 8.5 17 4 2 þ þ 
7 16/F U, V 1184 1.5 6.5 11 15 0 þ þ 
8 35/M OAS, U 48 0.5 1.3 8 8 2 þ þ 
9 16/F AD, A 660 23.0 22.0 10 11 2 þ þ ND
10 35/M U, A 380 48.0 56.0 23 18 5 þ þ ND
11 9/M U, OAS 1455 0.8 0.3 11 0 0 þ  
12 9/M AE, AP 745 6.4 8.0 24 13 1 þ þ 
13 11/M AP, OAS 116 7.7 9.4 8 12 2 þ þ ND
14 14/M C, U 345 0.8 1.1 11 12 0 þ þ *
15 15/M U, OAS 1218 2.0 1.1 18 4 0 þ þ ND
16 10/M U, OAS 1432 4.0 6.5 28 ND 0 þ þ 
17 11/M A, U 2297 >100.0 >100.0 9 ND 6 þ þ ND
18 12/M A, AE, AP 723 >100.0 >100.0 18 ND 15 þ þ †þ
Median NA NA 734 4.9 6.5 11 11 2 NA NA NA
A, Asthma; AD, atopic dermatitis; AE, angioedema; AP, abdominal pain; C, conjunctivitis; F, female; M, male; NA, not available; ND, not determined; OAS, oral allergy
syndrome; U, urticaria; V, vomiting.
Reactivity to bony and cartilaginous fish was explored by PPT with cooked fish and the wheal size (mm) is indicated. Information about clinical reactivity is based on self-report
or diagnostic food challenges.
*Open food challenge.
†Double-blind placebo-controlled food challenge.
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parvalbumins
Purified parvalbumins used in this study are listed in Table II.
Detailed purification and characterization procedures are available in
this article’s Method’s section in the Online Repository at www.jaci-
inpractice.org.
ELISA
Quantification of parvalbumin-specific serum IgE in patients
allergic to fish and controls was performed by ELISA as previously
described.23 Five b-parvalbumins and 3 a-parvalbumins were used.
Specific IgE values of greater than 0.1 kUA/L were rated positive.
Negative values were rated as 0.1 kUA/L.
Inhibition ELISA
Cross-reactivities betweenb-parvalbumins anda-parvalbuminswere
analyzed by inhibition ELISA. Plates were coated with 1 mg/mL cod
b-parvalbumin. Sera from 10 individuals allergic to fish were pre-
incubated with b-parvalbumins from cod (self-inhibition) or salmon, or
with ray a-parvalbumin at serial dilutions (0.01-100 mg/mL). Binding
of serum IgE to coated cod parvalbuminwas determined as described.23
Basophil activation test
Basophil activation on stimulation with increasing concentrations
of parvalbumins was assessed using the Flow-CAST kit (Bühlmann
Laboratories AG, Schönenbuch, Switzerland) according to the
manufacturer’s protocol. The gating strategy is shown in Figure E2
in this article's Online Repository at www.jaci-inpractice.org.
Detailed methods of the BAT are specified in this article’s Methods
section in the Online Repository.Skin prick testing with purified parvalbumins
SPT was performed in patients allergic to fish using purified natural
parvalbumins (0.1, 1, 10, and 50 mg parvalbumin/mL) diluted in saline
containing 0.03% human serum albumin (ALK, Inc., Hørsholm,
Denmark). b-Parvalbumins from cod, carp, and salmon and a-parval-
bumins from ray and shark were used. In the children with a clinical
history of severe allergic reactions to fish, the number of parvalbumins
was reduced by excluding b-parvalbumins from carp, salmon, or both.
Skin test resultswere rated positive when the averagewheal diameter was
greater than or equal to 3 mm compared with that achieved with saline.RESULTS
Demographic and clinical characteristics of study
subjects
Eighteen individuals with fish allergy (mean age, 16 years)
and 7 controls (mean age, 29 years) were included in this
study. Total serum IgE level ranged from 46 to 2297 kU/L for
individuals with fish allergy and from 59 to 1121 kU/L for
controls (Table I and Table E1). Severity of the clinical
symptoms of fish allergy varied, including asthma, urticaria,
and gastrointestinal symptoms (Table I). Sensitization to cod
and salmon was confirmed by ImmunoCAP with the
respective fish extracts. Specific IgE titers for cod ranged from
0.2 kUA/L to more than 100 kUA/L (median, 4.9 kUA/L).
IgE specific to salmon ranged from 0.3 to more than 100
kUA/L (median, 6.5 kUA/L) (Table I). All patients were
positive for both cod and salmon in ImmunoCAP according to
cutoff of 0.1 kUA/L.
TABLE II. Parvalbumins investigated in the study
Species
(common name)
Species
(scientific name)
Allergen
name
Parvalbumin
lineage
Parvalbumin used in
ELISA and BAT
Parvalbumin
used in SPT
Atlantic cod Gadus mohrua Gad m 1 b n n
Common carp Cyprinus carpio Cyp c 1 b n n
Atlantic salmon Salmo salar Sal s 1 b n n
Atlantic salmon Salmo salar NA a r —
Barramundi Lates calcarifer Lat c 1 b n —
Nile tilapia Oreochromis niloticus NA b n —
Thornback ray Raja clavata NA a n n
Gummy shark Mustelus antarcticus NA a n n
n, Natural; NA, not available; r, recombinant; —, not used.
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To explore the reactivity of patients allergic to fish to ray, a
cartilaginous fish, PPTs with cooked cod, salmon, and ray were
performed (Table I). All patients reacted to at least 1 bony fish
(17 of 18 for cod, median wheal diameter, 11 mm; 14 of 15 for
salmon, median wheal diameter, 11 mm). In contrast, PPTs with
ray demonstrated positive reactions in only 4 of 18 patients, with
a median wheal diameter of 2 mm for all patients (Table I). For
the group of positive patients in PPT with ray (P4, P10, P17,
and P18), the mean wheal diameter was 7 mm. In case of the
other 14 patients, negative in PPT with ray, the mean wheal
diameter was 1 mm.
Clinical reactivity to bony fish correlated with PPT results,
with 16 of 18 patients being positive to both cod and salmon,
whereas P2 and P11 reacted only to salmon or cod, respectively.
Clinical reactivity on ingestion of ray was assessed in 11 patients,
of which 10 were negative and tolerated this fish. The only
patient showing allergic symptoms after ingestion of ray (double-
blind placebo-controlled food challenge) was P18, who had a
positive result in PPT with ray (average wheal diameter, 15 mm)
(Table I).
Characterization of the parvalbumins
Eight fish parvalbumins (5 b and 3 a) were purified and used
in the study (Table II). Their purity was demonstrated by
Coomassie brilliant blue staining of SDS gels (see Figure E3, A,
in this article’s Online Repository at www.jaci-inpractice.org).
Protein identity was confirmed by Western blotting with anti-
parvalbumin antibodies (Figure E3, B). All parvalbumins
demonstrated the expected a-helical secondary structure, as
determined by circular dichroism spectroscopy (Figure E3, C).
Membership to the a or b lineage of parvalbumins was
confirmed by Matrix-Assisted Laser Desorption/Ionization
Time-of-Flight (MALDI-TOF) mass spectrometry (data not
shown).
Low IgE titers to a-parvalbumins from cartilaginous
fish
IgE titers for a-parvalbumins from cartilaginous fish (ray, shark)
were significantly lower compared with IgE titers for any of the
tested b-parvalbumins (eg, cod vs shark, P < .05; tilapia vs ray,
P < .0001; Figure 1, A; see Table E2 in this article’s Online Re-
pository at www.jaci-inpractice.org). No significant difference
between IgE titers for different b-parvalbumins was observed
(Table E2). IgE levels to salmon a-parvalbumin were lower than to
b-parvalbumins, but higher than to cartilaginous fisha-parvalbumins (median IgE to b-parvalbumins, 1.6 kUA/L;
salmon a-parvalbumin, 0.2 kUA/L; ray and shark a-parvalbumins,
0.1 kUA/L; Figure 1, A; see Table E3 in this article’s Online
Repository at www.jaci-inpractice.org).
All 18 patients exhibited positive IgE titers (0.2-72 kUA/L) to
at least 1 of the b-parvalbumins (Figure 1, B; Table E3).
Seventeen of 18 patients had IgE for multiple b-parvalbumins,
while P2 was monosensitized to salmon b-parvalbumin, which
was in accordance with the clinical reactivity of this patient
(Figure 1, B, and Table I). Positive IgE titers to ray and shark
parvalbumin were found in 2 and 6 patients, respectively, and
were generally lower compared with IgE titers to b-parvalbumins
in corresponding patients (Figure 1, B, and Table E3).
Specific IgE levels to all tested parvalbumins were below the
detection limit in control subjects (data not shown).
Weak IgE cross-reactivity between codb-parvalbumin
and ray a-parvalbumin
IgE cross-reactivity between cod b-parvalbumin and salmon
b-parvalbumin or ray a-parvalbumin was analyzed. The con-
centration of cod parvalbumin required to reach 50% inhibition
of IgE-binding to cod parvalbumin was as low as 0.01 mg/mL for
7 of 10 subjects. The highest tested concentration of the
inhibitor (100 mg/mL) resulted in an inhibition of more than
90% of IgE-binding in all tested individuals (Figure 2, A).
The cross-reactivity between cod and salmon b-parvalbumins
was patient-dependent. To inhibit IgE-binding to cod parval-
bumin by 50%, 0.01 mg/mL salmon b-parvalbumin was required
for P1, P7, and P13. An inhibitor concentration of 0.1 mg/mL
inhibited binding to cod parvalbumin in 3 additional patients
(P3, P10, and P12). The highest tested inhibitor concentration
resulted in more than 50% inhibition in 9 of 10 patients. For P9,
inhibition did not reach 50% in the tested range of inhibitor
concentrations (Figure 2, B).
IgE cross-reactivity between cod and ray parvalbumins was
very low. Ray parvalbumin induced more than 50% inhibition
only when used in the highest concentration (100 mg/mL) in 8 of
10 subjects. For P9 and P13, the inhibition did not reach 50% in
the tested range of inhibitor concentrations (Figure 2, C).
Low basophil activation in response to fish
a-parvalbumins
a-Parvalbumins from ray, shark, and salmon demonstrated
lower capacity to activate basophils than did b-parvalbumins from
cod, carp, and salmon (Figure 3). On stimulation with 100 ng/mL
parvalbumins, themedian amount of CD63þ basophils was 13.9%
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and b-parvalbumins among 18 patients allergic to fish were determined by ELISA. B, Patient-specific IgE recognition patterns to a-par-
valbumins and b-parvalbumins. The signal intensity of parvalbumin-specific IgE is represented in a grading log10 scale for concentrations
of measured parvalbumin-specific IgE (kUA/L).
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1.2% with a-parvalbumins (Figure 3; see Table E4 in this article’s
Online Repository at www.jaci-inpractice.org). The difference in
basophil activation capacity between a-parvalbumins from carti-
laginous fish and any of the tested b-parvalbumins was statistically
significant (eg, ray vs cod, P< .001; shark vs cod, P< .01; n¼ 18)
(see Table E5 in this article’s Online Repository at www.jaci-
inpractice.org). Response to salmon a-parvalbumin was signifi-
cantly lower than to cod and salmon b-parvalbumins but not when
compared with carp parvalbumin (Table E5). Fourteen of 18
patients demonstrated positive reactions to at least 1 of the
parvalbumins. All 14 patients were positive to b-parvalbumins,
whereas only 2 (P12 and P18) reacted to a-parvalbumins as well
when proteins were used at concentrations up to 100 ng/mL
(Table E4; see Figure E4 in this article’s Online Repository at
www.jaci-inpractice.org). Furthermore, the concentration of
a-parvalbumins required to elicit a positive response was higher
than that of b-parvalbumins.
All patients responded positively to the stimulation with an
anti-FcεRI mAb, whereas 16 of 18 patients responded to formyl-
methionyl-leucyl-phenylalanine stimulation (Figure E5, available
in this article's Online Repository at www.jaci-inpractice.org).None of the controls demonstrated a positive basophil activation
in response to stimulation with parvalbumins in a concentration
of up to 10 mg/mL (data not shown).
Weak skin prick reactivity to a-parvalbumins in
patients allergic to bony fish
b-Parvalbumins from cod, carp, and salmon induced positive
skin reactions in 94%, 78%, and 80% of the tested patients,
respectively (Figure 4). In contrast, each of the a-parvalbumins
induced positive skin reactions in only 3 of 16 patients. Further-
more, the parvalbumin concentration needed to induce positive
skin reactions was 100- to 500-fold higher for a-parvalbumins
than for b-parvalbumins (Figure 4; see Table E6 in this article’s
Online Repository at www.jaci-inpractice.org). Detailed results of
the SPT for patients allergic to fish are presented in Table E6.
Negative control (saline) did not induce any skin reaction.
DISCUSSION
Fish-allergic individuals are generally advised to avoid all fish
due to the potential risk of reacting to a wide variety of species in
addition to the primary sensitizing source.18,27 Although many
studies have described different species of bony fish as highly
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FIGURE 2. IgE antibody cross-reactivity of cod b-parvalbumin to
salmon (b) and ray (a) parvalbumin determined by inhibition ELISA
in patients allergic to bony fish (n ¼ 10). Microtiter plates were
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b-parvalbumin (A), salmon b-parvalbumin (B), or ray a-parvalbu-
min (C) at increasing concentrations.
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fish are rare and contradictory.5-7 Because of the lack of
knowledge about the allergenicity of alternative fish sources suchas cartilaginous fish, patients may be subjected to unnecessary
food restrictions, possibly influencing their dietary requirements
and quality of life.19,28
Most patients with fish allergy are sensitized to b-parvalbu-
mins present in the muscle of bony fish.24,29 Parvalbumins of the
a-lineage are abundant in muscle tissue of cartilaginous fish and
higher vertebrates.24 Chicken and frog a-parvalbumins were
shown to be responsible for IgE cross-reactivity to bony fish
b-parvalbumins in some of the patients allergic to fish.30,31
However, only 1 study explored the sensitization to an a-par-
valbumin from cartilaginous fish.25 In this study, Cai et al25
demonstrated IgE-binding to parvalbumin from red stingray in
patients allergic to bony fish by IgE immunoblotting but no
functional assays or in vivo studies were performed.
Here, we analyzed the allergenicity of cartilaginous fish and
their parvalbumins in patients with allergy to bony fish. We were
able to demonstrate low reactivity to ray, a cartilaginous fish, by
PPT (median wheal diameter, 2 mm; n ¼ 18). Furthermore, 11
patients were tested for tolerance of ray, 10 of which were able to
consume a serving dose of ray without developing allergic
symptoms (Table I). Only P18 had a positive reaction to ray on
double-blind placebo-controlled food challenge, which was in
accordance with his skin reaction in PPT with cooked ray. In
addition, P10 and P17 demonstrated positive skin reactions to
cooked ray. However, these 2 patients did not agree to undergo a
food challenge and their clinical reactivity to ray could not be
confirmed.
To our knowledge, besides the study from Cai et al,25 only 2
other studies explored the IgE reactivity to cartilaginous fish.
Calderon-Rodriguez et al5 demonstrated low allergenicity of
cooked dogfish sharks in 34 patients with fish allergy. However,
PPT result with raw dogfish was positive in 6 patients, possibly
demonstrating sensitization to fish allergens that are not heat-
stable. A study from Koyama et al7 that examined patients’
IgE-binding to raw extracts from 43 fish species demonstrated a
low IgE recognition of cartilaginous compared with bony fish.7
To dissect the molecular basis of the observed tolerance to
cartilaginous fish in patients with confirmed allergy to bony
fish, we explored IgE reactivity to fish a-parvalbumins and
b-parvalbumins in our patient cohort. Levels of IgE specific to
a-parvalbumins from cartilaginous fish were significantly lower
than to bony fish b-parvalbumins (Figure 1 and Tables E2 and
E3). Previous studies demonstrated high cross-reactivity of
b-parvalbumins from different fish species; however, the cross-
reactivity between fish b-parvalbumins and a-parvalbumins has
not been explored.27,32,33 We demonstrated patient-dependent
IgE cross-reactivity between cod and salmon b-parvalbumins by
inhibition ELISA. Interestingly, the cross-reactivity between par-
valbumins from cod (b) and ray (a) was strikingly low (Figure 2).
BATs further confirmed the low IgE reactivity ofa-parvalbumins
in our patient cohort (Figure 3). Overall, 14 of 18 patients
demonstrated positive reactions with any of the tested parvalbu-
mins. All 14 patients were positive to b-parvalbumins and only 3
reacted to a-parvalbumins when tested up to 1000 ng/mL. Four
patients did not respond to purified parvalbumins in BAT possibly
due to the low parvalbumin-specific IgE levels compared with the
total IgE levels in these patients (P2, P6, P11, and P15). Further-
more, these patients may have been sensitized to other fish allergens
such as aldolase A, b-enolase, or collagen.23,34 Previous studies have
tested the capacity of BAT to diagnose food allergy and have shown
that it has superior specificity and comparable sensitivity compared
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FIGURE 3. Basophil response to a-parvalbumins was lower than to b-parvalbumins. Data indicate basophil activation (measured as
percentage of CD63þ basophils) in response to stimulation with different doses of fish parvalbumins in patients allergic to fish (n ¼ 18).
FIGURE 4. a-Parvalbumins show lower capacity than b-parvalbumins to induce skin reactions in patients allergic to fish. SPTs were
performed with different doses of natural purified fish parvalbumins. Parvalbumins were used in concentrations ranging from 0.1 mg/mL to
50 mg/mL. Averagewheal diameter of greater than or equal to 3 mm compared with negative control was rated as a positive response. (X)
indicates that SPTwas not performed.
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never been investigated as an additional diagnostic tool for fish al-
lergy. In our study, parvalbumin reactivity in BAT was comparable
to reactivity in ELISA and SPT in case of b-parvalbumins for all 14
patients who reacted positively in BAT. However, quantitatively,
the Spearman correlation test did not demonstrate a significant
correlation between the titer of parvalbumin-specific IgE (ELISA)
and reactivity in BAT (see Table E7 in this article’s Online Re-
pository at www.jaci-inpractice.org).
Lower reactivity to a-parvalbumins compared with b-parval-
bumins was further confirmed by SPT with purified natural par-
valbumins (Figure 4). Only 5 of 16 patients were positive to ray orshark parvalbumin, and the concentration of a-parvalbumins
needed to elicit positive reactions was in all cases higher than the
concentrations of b-parvalbumins in the corresponding patients.
The observed difference in allergenicity between fish b-par-
valbumins and a-parvalbumins may be explained by low
sequence identity between these 2 parvalbumin lineages (<50%
sequence identity between a-parvalbumin from leopard shark or
thornback ray and b-parvalbumins from cod, carp, or
salmon).4,16 Interestingly, sequence identity between fish
b-parvalbumins and a-parvalbumin from frog and chicken is
higher than 50%, possibly contributing to occasional cross-
reactivities between these species.4,36
J ALLERGY CLIN IMMUNOL PRACT
VOLUME 7, NUMBER 2
KALIC ETAL 507Most commonly used in vitro diagnostic platforms for fish
allergy such as the ImmunoCAP Rapid, ImmunoCAP ISAC
(Thermo Scientific), and MADx (Macro Array Diagnostics,
Vienna, Austria) are based on quantification of IgE against ex-
tracts from a total of 28 different fish species and 2 recombinant
b-parvalbumins (cod and carp).16 Cartilaginous fish, such as
different species of rays and sharks, are not included in these
tests. Cartilaginous fish have been described as equal in nutri-
tional value to bony fish and have multiple health benefits.37,38
The inclusion of specific cartilaginous fish species and their
parvalbumins in the current diagnostic assays would be essential
to confirm the tolerance among patients allergic to fish, even-
tually resulting in less stringent curtailment of the diet of in-
dividuals allergic to fish.
Our study demonstrated that IgE reactivity to parvalbumin
may predict the clinical reactivity to specific fish species.
However, it is important to note that some patients may be
sensitized to other, minor fish allergens such as aldolase A, b-
enolase, or collagen.23,34 Because cartilaginous fish is most
commonly consumed cooked, we performed IgE immunoblots
with extracts of raw and cooked ray (see the Methods section and
Figure E6 in this article's Online Repository at www.jaci-
inpractice.org). Only 1 of 14 patients tested was found to be
positive to ray enolase and 2 patients to ray aldolase when tested
on an extract of raw ray. However, these 2 patients were negative
to these 2 allergens when tested on extract of cooked ray
(Figure E6, E). None of the patients showed IgE-binding to ray
collagen (expected molecular weight of collagen a-chain, w110
kDa) (Figure E6, E).
Currently, diagnostic testing (PPT, food challenges, or both)
for several cartilaginous fish species can be recommended to
explore the possibility of tolerance of cartilaginous fish in
individuals sensitized to bony fish. A limitation of this study is
the low number of patients tested for tolerance to ray using food
challenges, as well as the number of explored cartilaginous fish
species. Future studies investigating the potential tolerance of
several cartilaginous fish species in a larger patient cohort will
help to develop a diagnostic workup of patients with fish allergies
and improve patient management.
In summary, our study demonstrated the low allergenicity of
ray and fish a-parvalbumins in patients sensitized and allergic to
bony fish. Inclusion of cartilaginous fish in routine diagnosis of
fish allergy may prevent unnecessary food restrictions. This
approach represents a first step toward precision medicine in
patients allergic to fish leading to improved quality of life of
affected individuals.
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METHODS
Purification and characterization of the study
parvalbumins
Natural b-parvalbumins were purified from Atlantic cod
(Gadus morhua), common carp (Cyprinus carpio), Atlantic
salmon (Salmo salar), barramundi (Asian sea bass, Lates calcari-
fer), and Nile tilapia (Oreochromis niloticus). Natural a-parval-
bumins were purified from thornback ray (Raja clavata) and
gummy shark (Mustelus antarcticus). To explore the allergenicity
of an a-parvalbumin from bony fish and to compare it with the
b-counterpart from the same species, a recombinant a-parval-
bumin from Atlantic salmon (Uniprot ID: C0HAT9) was
expressed in Escherichia coli and purified.
Natural cod and ray parvalbumins were purified from extracts
of muscle tissue of the respective fish species using sequential ion-
exchange and size exclusion chromatography following the
methods described in previous studies.E1,E2
For purification of carp parvalbumin, a protein extract was
prepared by stirring homogenized carp muscle tissue in 3 vol-
umes of PBS overnight at 4C. The extract was centrifuged to
remove cell debris and heated to 95C for 30 minutes. Precipi-
tated proteins were removed by centrifugation and the super-
natant dialyzed against 20 mM Bis-Tris buffer (pH 6.5) and
applied to a Q Sepharose ion-exchange column (GE Healthcare,
Chicago, Ill). Bound proteins were eluted from the column by a
linear salt gradient from 0% to 50% elution buffer (20 mM Bis-
Tris, 1 mol NaCl, pH 6.5). Fractions containing carp parval-
bumin were loaded onto HiPrep 26/60 Sephacryl S-200 High
Resolution Column (GE Healthcare) equilibrated with PBS.
Low-molecular-weight fractions containing carp parvalbumin
were dialyzed against 20 mM Bis-Tris, pH 5.5, and loaded onto
a Mono Q 5/50 GL Tricon column (GE Life Science). Pure carp
parvalbumin was eluted as a single peak from the column by a
linear salt gradient from 0% to 35% elution buffer (20 mM Bis-
tris, 1 mol NaCl, pH 5.5).
Natural parvalbumins from salmon (b), barramundi, tilapia,
and gummy shark were isolated using ammonium sulfate pre-
cipitation as previously described for mackerel.E3 Briefly, fish
muscle tissue was heated in PBS at 95C for 20 minutes. After
homogenization, overnight stirring at 4C, and centrifugation,
the parvalbumins were purified from the supernatant by
ammonium sulfate precipitation followed by dialyses against
ammonium bicarbonate buffer and subsequently PBS.
Recombinant salmon a-parvalbumin was expressed and
purified according to previously published procedures.E4
Purified parvalbumins were visualized by Coomassie brilliant
blue staining of the 15% SDS gels. Protein identity was
confirmed by Western blotting using 2 antiparvalbumin anti-
bodies (Swant, 235, an mAb raised against b-parvalbumin, and
Abcam, ab11427, a polyclonal antibody raised against a-par-
valbumin). Secondary structure of the purified parvalbumins was
determined by circular dichroism spectroscopy. Circular
dichroism spectra were measured from 190 to 250 nm
using Jasco J-810 spectropolarimeter (Jasco InternationalCo., Hachioji, Tokyo), and 5 separate acquisitions for each
protein were averaged. Presence of specific lineage (a or b) and
isoforms of natural purified parvalbumins was determined using
full-length proteins and Matrix-Assisted Laser Desorption/Ioni-
zation Time-of-Flight (MALDI-TOF) mass spectrometer
(Microflex, Bruker Daltonics, Bremen, Germany).
Basophil activation test
BAT was performed using the Flow-CAST kit (Bühlmann
Laboratories AG, Schönenbuch, Switzerland), according to the
protocol recommended by the manufacturer. Fresh blood
samples from 18 patients allergic to fish and 7 controls were
tested with b-parvalbumins from cod, carp, and salmon, and
a-parvalbumins from salmon, ray, and shark. Blood samples
were incubated with 10-fold serial dilution of allergens. For pa-
tients allergic to fish, parvalbumins were initially tested in di-
lutions between 0.1 and 100 ng/mL. Because for some of the
patients 100 ng/mL of the parvalbumins was not sufficient to
reach maximum basophil activation, patients were re-tested
wherever possible and parvalbumins in a concentration up to
1000 ng/mL were used. In control subjects, concentration of
parvalbumins used in BAT was up to 10,000 ng/mL. The
percentage of activated (CD63þ) basophils on stimulation was
determined by flow cytometry. CCR3 was used as a marker for
basophils. Stimulation buffer without parvalbumins was used as a
negative control. Formyl-methionyl-leucyl-phenylalanine and
anti-FcεRI antibody were used as positive controls. Data acqui-
sition and analysis were performed using BD FACSDiva (BD
Biosciences) and Kaluza (Beckman Coulter, Brea, Calif) soft-
wares, respectively. The gating strategy is represented in
Figure E5. The response was considered positive if the parval-
bumin induced an activation of more than 10% of the basophils.
Detection of minor fish allergens in ray extract
To explore the relevance of fish allergens other than parval-
bumins in cartilaginous fish, Western blots with antiparvalbumin
antibody as well as with antienolase and antialdolase antibodies
were performed with extracts from ray filet cooked for 5, 10, or
20 minutes, according to previously published protocols.E2
Uncooked fish was used as a control. Furthermore, IgE
immunoblots with extracts from raw and cooked (10 minutes)
ray filet were performed using sera of 14 patients, to analyze
whether IgE-binding bands were visible in the molecular weight
ranges of b-enolase, aldolase A, or collagen.E5
Statistical analysis
The nonparametric paired Friedman test was used for com-
parisons between the responses to different parvalbumins in
ELISA and BAT. Multiple comparisons were performed using
Dunn posttest. Data are expressed as medians. For the correla-
tion between parvalbumin-specific IgE and percentage of
activated basophils for each parvalbumin, the Spearman corre-
lation test was used, and P values adjusted using the Bonferroni
correction for multiple comparisons. The analyses were
performed using GraphPad Prism software version 7 (GraphPad
Software, La Jolla, Calif).
Fish-allergic patients (18)
Recommendation to introduce ray 
into diet (14)
Prick-to-prick test with ray (18)
Recommendation for food
challenge with ray (10)
Positive (4) Negative (14)
Patients afraid
to introduce
ray (6)
Confirmation of tolerance (8)Confirmation of allergy (1)or tolerance (2)
Patients disagree to perform food
challenge (7)
FIGURE E1. Diagnostic flowchart for assessing tolerance of ray. Numbers in parentheses represent the numbers of subjects for each step.
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FIGURE E2. Gating strategy in BAT. Basophilic cells were selected from whole blood based on CCR3high/SSClow. Activation of basophils
was determined by expression of an activation marker CD63. Expression of CD63 for unstimulated control, 2 stimulation controls (anti-
FCεRI mAb and fMLP), and stimulation with 100 ng/mL cod parvalbumin is demonstrated for P1 as an example. fMLP, Formyl-methionyl-
leucyl-phenylalanine.
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FIGURE E3. Characterization of parvalbumins from bony and cartilaginous fish species. A, Coomassie-stained SDS-PAGE gel of purified
parvalbumins. B,Western blot using commercial antiparvalbumin antibodies. C, Circular dichroism (CD) spectra of purified parvalbumins.
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FIGURE E4. BAT. Percentages of CD63þ basophils (y-axes) at different concentrations of b-parvalbumins and a-parvalbumins are rep-
resented for individual subjects allergic to fish (P1-P18).
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FIGURE E5. Response to positive (anti-FcεRI and fMLP) and negative (stimulation buffer) controls in BAT for subjects with fish allergy.
Ctrl, Control; fMLP, formyl-methionyl-leucyl-phenylalanine; Neg, negative; pos, positive.
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FIGURE E6. Detection of fish allergens in ray extract. A, Coomassie-stained SDS-PAGE of extract of raw ray filet and ray filet cooked for
5, 10, or 20 minutes. B-D, Immunoblots with ray extract using antiparvalbumin antibody (Fig E6, B), antienolase antibody (Fig E6, C), and
antialdolase antibody (Fig E6, D). E, IgE immunoblots using extract of raw ray filet. P, E, and A stand for controls parvalbumin, enolase and
aldolase, respectively. P4 and P6 were additionally tested on extract of cooked ray (4* and 6*). Ab, Antibody.
TABLE E1. Demographic and clinical characteristics of control
subjects
Control no. Sex Age (y) Total IgE (kU/L) Allergies
C1 M 17 1121 Peanut
C2 F 45 59 Pollen
C3 M 14 16 Hazelnut
C4 M 12 913 Peanut
C5 M 48 86 Wasp venom
C6 F 28 533 Grass pollen
C7 F 42 123 House dust mite
F, Female; M, male.
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TABLE E2. Comparison (Friedman test with Dunn posttest) of IgE levels specific to different purified parvalbumins*
Parvalbumin
Parvalbumin
Cod Carp Barramundi Tilapia Salmon b Salmon a Ray
Carp NS
Barramundi NS NS
Tilapia NS NS NS
Salmon b NS NS NS NS
Salmon a NS NS * NS NS
Ray † z z z x NS
Shark * x x z † NS NS
NS, Nonsignificant.
Refer to Figure 1 and Table E3 for IgE quantification data.
*P < .05.
†P < .01.
zP < .001.
xP < .0001.
TABLE E3. Quantification of parvalbumin-specific IgE antibodies (kUA/L) in sera of fish-allergic subjects using direct ELISA*
Patient no. Cod Carp Barramundi Tilapia Salmon b Salmon a Ray Shark
P1 1.6 1.9 2.2 1.7 1.5 0.2 0.1 0.8
P2 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1
P3 17.1 27.7 2.4 0.6 10.6 33.9 0.1 0.2
P4 1.2 0.5 0.9 0.9 0.9 0.1 0.1 0.1
P5 1.2 1.5 1.4 1.4 2.1 0.9 0.1 0.1
P6 0.2 0.1 0.2 0.2 0.6 0.1 0.1 0.1
P7 1.1 2.7 2.4 2.0 1.4 1.3 0.1 0.1
P8 0.2 0.4 0.5 0.6 0.5 0.1 0.1 0.2
P9 19.3 29 24.0 16.0 14 0.1 0.1 0.1
P10 14.9 16 26.0 19.0 14.5 2 0.1 0.1
P11 0.7 0.7 0.7 0.7 0.4 0.1 0.1 0.1
P12 6.2 8.1 9.0 9.1 7.8 1.1 0.1 0.1
P13 27.6 40.6 41.0 41.0 23.3 4.2 0.1 2.3
P14 1.7 2.1 1.8 2.0 1.2 0.1 0.1 0.1
P15 1.1 0.9 0.5 1.1 0.1 0.1 0.1 0.1
P16 1.9 1.8 2.5 2.4 2.8 0.3 0.1 0.1
P17 65.1 72 51.5 7.5 60.5 77 46.5 76
P18 53.4 57 58 60 61 58.8 39.2 44
Average 11.9 14.6 12.5 9.2 11.3 10.0 4.8 6.9
Median 1.6 2 2.3 1.8 1.8 0.2 0.1 0.1
Positive patients (%) 94.4 88.9 94.4 94.4 94.4 55.6 11.1 33.3
*Values above 0.1 kUA/L were regarded as positive.
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TABLE E4. Percentage of CD63þ basophils in blood of patients
allergic to fish after stimulation with 100 ng/mL parvalbumins
Patient
no. Cod Carp
Salmon
b
Salmon
a Ray Shark
P1 46.8 62.5 70.4 ND 0.1 0.1
P2 0.4 0.1 2.1 ND 0.1 0.1
P3 22.0 17.0 6.0 0.6 0.2 1.0
P4 27.7 17.2 5.0 2.2 2.0 5.8
P5 4.7 4.7 21.6 2.4 4.0 1.6
P6 0.8 0.6 2.6 ND 0.6 0.2
P7 4.6 6.4 15.3 ND 0.6 1.2
P8 77.7 88.5 87.4 ND 0.2 0.2
P9 13.6 10.8 15.5 ND 1.0 1.6
P10 70.7 56.5 85.1 ND 0.4 0.4
P11 0.2 0.2 0.2 0.1 0.2 0.4
P12 50.0 42.0 51.0 6.0 20.0 18.0
P13 16.8 20.0 19.1 1.2 0.8 1.2
P14 15.5 9.8 7.6 1.6 1.4 2.4
P15 1.2 0.4 1.2 1.0 1.2 0.4
P16 9.6 5.0 1.6 0.8 0.6 0.6
P17 85.6 62.8 62.4 1.2 1.7 1.1
P18 55.4 49.8 65.4 35.8 26.1 31.2
Average 28.0 25.2 28.9 4.8 3.4 3.7
Median 16.2 13.9 15.4 1.2 0.7 1.1
Positive
patients
(%)
61.1 55.6 55.6 9.1 5.6 5.6
ND, Not determined.
TABLE E5. Comparison (Friedman test with Dunn posttest) of
basophil response to stimulation with 100 ng/mL parvalbumins*
Parvalbumin
Parvalbumin
Cod Carp Salmon b Salmon a Ray
Carp NS
Salmon b NS NS
Salmon a † NS z
Ray x † jj NS
Shark † z x NS NS
NS, Nonsignificant.
*Refer to Figure 3, Table E4, and Figure E2 for BAT data.
†P < .05.
zP < .01.
xP < .001.
jjP < .0001.
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TABLE E6. SPTwith purified parvalbumins*
Parvalbumin mg/mL P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17 P18
Cod 0.1 3 0 0 0 1 0 0 3 4 ND 0 2 0 4 0 6 1 ND
1 3 0 0 1 2 0 2 ND ND ND 0 5 2 ND 2 ND 7 ND
10 ND 0 7 4 2 2 2 ND ND ND 2 ND 3 ND 2 ND ND ND
50 ND 0 ND ND 4 3 7 ND ND ND 4 ND ND ND 7 ND ND ND
Carp 0.1 3 ND 0 ND 1 0 0 4 3 ND ND 2 ND ND 0 ND ND ND
1 7 ND 0 ND 2 0 1 ND ND ND ND 3 ND ND 0 ND ND ND
10 ND ND 2 ND ND 0 5 ND ND ND ND ND ND ND 0 ND ND ND
50 ND ND 11 ND ND 3 ND ND ND ND ND ND ND ND 0 ND ND ND
Salmon b 0.1 3 ND 0 ND 1 0 2 3 5 ND ND 3 ND ND 0 ND ND ND
1 10 ND 0 1 1 2 3 ND ND ND ND ND ND ND 0 ND ND ND
10 ND ND 2 2 4 6 ND ND ND ND ND ND ND ND 0 ND ND ND
50 ND ND 7 2 ND ND ND ND ND ND ND ND ND ND 0 ND ND ND
Ray 0.1 0 0 0 0 0 ND ND 0 1 ND 0 0 0 0 0 2 0 ND
1 2 0 0 0 0 ND ND 0 1 ND 0 0 0 0 0 0 0 ND
10 1 0 0 0 0 1 0 1 0 ND 0 0 0 2 0 0 0 ND
50 3 0 0 1 0 0 0 3 3 ND 0 0 0 2 0 0 2 ND
Shark 0.1 0 0 0 0 0 ND ND 0 0 ND 0 0 0 0 0 0 0 ND
1 0 0 0 0 0 ND ND 0 0 ND 0 0 0 0 0 0 0 ND
10 0 0 0 0 0 1 0 2 1 ND 2 0 0 1 0 0 0 ND
50 1 0 1 1 0 2 0 1 3 ND ND 2 0 3 0 0 3 ND
ND, Not determined.
*Numbers indicate average wheal diameter (mm).
TABLE E7. Spearman correlation test for the amount of
parvalbumin-specific IgE (ELISA) and the percentage of activated
basophils with 100 ng/mL parvalbumins (BAT)*
Parvalbumin Spearman r Corrected P value
Cod 0.5974 0.0516
Carp 0.5266 0.1398
Salmon b 0.5658 0.0833
Salmon a 0.2378 0.9791
Ray 0.4367 0.3530
Shark 0.0012 1
*P values listed in the table were obtained using the Bonferroni correction for
multiple comparisons (Pcorrected ¼ 1  (1  Puncorrected),6 where 6 is the number of
independent comparisons.
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